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Compliance in diabetes  
— target or way to success?
ABSTRACT
In medicine, the term “compliance” is associated with 
medical practice and guidance, especially in relation to 
chronic diseases. Its definition has evolved with the de-
velopment of modern medicine. In the last decade, the 
relationship between patient and doctor has changed 
significantly. The increasing importance of therapeutic 
success is attributed to the personalization of medi-
cine and the consideration of patients’ perspectives 
and preferences. The purpose of this manuscript is to 
find a modern definition of the term compliance in 
relation to diabetes and to determine what elements 
of personalized medicine can be incorporated into 
patient care to improve overall clinical success. In this 
article, the authors discuss the topics of compliance 
and personalized medicine in diabetes care taking into 
account both available medical publications as well as 
many years of the authors’ own clinical experience. 
(Clin Diabet 2016; 5, 1: 32–39)
Key words: diabetes, compliance, patient,  
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Introduction
A “Successful” treatment of diabetic patients seems 
to be clearly defined by clinical guidelines — as sustain-
ing the desired glycemia, arterial pressure, lipid levels 
and body mass, thus preventing the occurrence of late 
complications and supporting patient’s good quality of 
life. It is widely agreed that we have a number of ef-
fective antihiperglycemic, hypotensive or hypolipidemic 
drugs at our disposal. In the course of every patient’s 
visit, we try to clearly communicate the desired way 
of treatment, encouraging him to follow it, gradually 
proceeding further with his education. However many 
of us would also admit that despite these scrupulous 
endeavours, our predefined goals are reached not quite 
as often as we would expect. Naturally, a question we 
ask ourselves is “why?” and, in many cases, a natural 
answer occurs, should we be frank about it: “because 
the patient doesn’t follow my recommendations and 
does whatever he or she wants…”. Nevertheless, as-
suming that every patient’s greatest concern is his 
health and that he makes effort to proceed the best 
he can in given circumstances, it seems justified to try 
and take his viewpoint into account, creating a compre-
hensive perspective of the doctor-patient relationship, 
to which the term “compliance” is inseparably related. 
Compliance is a term connected with therapeutic 
management and refers mainly to chronic diseases. 
However, its definition has evolved along with the de-
velopment of modern medicine. A traditional viewpoint 
on compliance pictured it as the extent of following 
the therapeutic guidance by the patient — as a result, 
the doctor-patient relationship was usually reduced 
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to presenting recommendations and overseeing their 
application [1]. In the last decade, both therapeutic 
guidelines concerning chronic diseases — including 
diabetes — and everyday clinical practice have seen a 
significant change of how the doctor-patient relation-
ship is perceived. Increasing importance of therapeutic 
success is attributed to the personalization of medicine 
and consideration of patients’ perspectives and prefer-
ences.
The purpose of this manuscript is to find a modern 
definition of the term compliance in relation to diabe-
tes and to determine what elements of personalized 
medicine can be incorporated into patient’s care to 
improve overall clinical success.
In this article, the authors discuss the topics of 
compliance and personalized medicine in diabetes care 
taking into account both available medical publica-
tions as well as many years of the authors’ own clinical 
experience. We are fully aware that the descriptions 
included in certain parts of this article are to some 
extent generalisations and may not cover the depth 
of the topics mentioned completely, as each of them 
could be elaborated on separately. Nevertheless, we do 
hope that this article will contribute to the discussion 
among practicing physicians. 
Definition of compliance
The English term compliance despite being 
a generally accepted and widespread medical defini-
tion, remains open to interpretation while being used 
in everyday speech. A quick dictionary search for 
a polish definition reveals many denotations, such as: 
subordination, conformance, submissiveness, pliancy 
or simply — cooperation. Many medical definitions 
also exist, ranging from straightforward — “two 
people cooperating to achieve various goals” [2] — to 
more complex descriptions, such as “any behaviour 
that brings the patient closer to achieving therapeutic 
goals” [3]. In addition, the term “compliance” is usu-
ally discussed inseparably with the terms “adherence” 
and “persistence”, sharing many common semantic 
elements with them, despite not being directly included 
in their definition. These common parts, as regarded 
by the authors, are presented in the Table 1.
In addition, the authors point out five areas that 
may greatly affect attaining compliance in therapy of 
diabetes (Fig. 1), which are described in the latter parts 
of the manuscript. 
Communication
Communication is one of the fundamental parts of 
an effective cooperation between the doctor and his 
patients. In its basic form, communication in a diabetic 
office is a mutual process of exchanging information 
between the patient and the doctor, the patient and 
the nurse or the doctor and the patient’s family. Dur-
Table 1. Definition of compliance and related terms
Compliance — the quality of intentional, mutual cooperation 
between the doctor and the patient, resulting in accomplish-
ment of therapeutic goals 
Compliance includes the following elements:
Adherence — the extent to which the patient follows and 
fulfils the therapeutic guidance 
Persistence — the long-lasting obedience and perseverance 
in fulfilling the guidance
Figure 1. Five areas that greatly affect compliance
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ing the consultation the doctor shares his knowledge 
with the patient, providing data concerning the chosen 
therapeutic option. On the other hand, the patient is 
the only source of information about his state of health, 
wellbeing and the ability of following the proposed 
therapy. Without effective communication it would be 
virtually impossible to educate the patient, involve him 
in the therapeutic process or sufficiently motivate him 
to seize control over his disease for a longer period of 
time [4]. Communication is the cornerstone of creat-
ing a trust-driven relationship between the doctor and 
the patient. Establishing such relationship may greatly 
contribute to following the doctor’s guidance and, as 
a result, achieving the patient’s therapeutic goals [5]. 
In authors’ opinion, the key aspects of communica-
tion are:
1. Adjusting the form and content  
of the message to the patient’s knowledge, 
abilities and comprehension
At its core, the main goal of communication is 
handing over the therapeutic guidance stemming 
from the doctor’s knowledge and clinical experience. 
However these alone may be insufficient for this guid-
ance to be understood, accepted and implemented. It 
is necessary to pass the information on in a compre-
hensible and plain manner, allowing it to be used and 
accepted by the patient. Emphasising the benefits of 
following the guidance and therefore controlling the 
disease, is a remarkably efficient way of communicat-
ing with the patient.
2. Preparing a schedule of the visit
One of the ways to reduce the impact of emo-
tions on the efficiency of communication is preparing 
a schedule of the patient’s visit. This allows preparing 
beforehand for a possible emotional response from 
our partner in dialogue, (e.g. in case of unfortunate 
news) and provides a resort in case of unexpected 
circumstances. One should also remember that verbal 
communication and a well adjusted message are only 
one part of the issue. Other elements, such as the vo-
cal aspect, consisting of using proper voice pitch and 
timbre, or the visual aspect involving i.e. the appear-
ance of the sender/receiver and their involvement in the 
conversation, facial expressions and gestures — may all 
contribute greatly to the process of communication [6].
3. Striving for feedback and reassuring  
comprehension
The communication between a diabetologist and 
his patient is a two-way process. Hearing the informa-
tion that is channelled from the patient to his doctor 
is, besides reaching the patient with our own message, 
also essential to a successful therapy [7]. The doctor 
should react accordingly to the information given by 
the patient and answer his questions, being especially 
attentive when it comes to showing care and empa-
thy, as well as keeping the message consistent with 
the ones handed out during prior visits. An effective 
method of assuring comprehension of the knowledge 
given is hearing the patient’s feedback carefully, and 
kindly asking him to repeat the information in his 
own words [8].
4. Using additional tools and communication 
channels
Handing out additional materials during the visits, 
such as medical guidelines or diabetic diaries, is a good 
way of increasing the efficiency of communication. Using 
such tools simplifies and standardizes the communication 
process, making its effect last longer than just the duration 
of the visit. A diabetic diary (or a personal insulin pomp data 
log or a constant glucose measurement system) makes the 
patient’s input more objective, to some extent. An interest-
ing way of reaching beyond the time of the visit is using 
electronic and mobile communication, although it requires 
the aid of additional personnel and is currently unavailable 
to polish doctors due to legal and practical issues. 
5. Establishing proper conditions  
for communication
An effective communication between the doctor 
and the patient may be affected by both intrinsic factors 
(e.g. personality or a specific emotional setting on the 
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day of the visit) and external factors (e.g. noise outside 
or a mobile phone ringing) [9]. 
Communication between the doctor and the 
patient may have a great influence on achieving po-
tential success of the therapy [10]. It is recommended 
for doctors to expand and develop their skills in that 
matter. Such process of self-improvement is a key also 
because of the new tools, solutions and therapeutic 
methods constantly emerging (e.g. insulin pumps with 
constant glucose measuring systems). These can bring 
real benefits to the patients, but also require the doc-
tors to adjust their communication to fit modern reality. 
Education
Educating a person with diabetes is one of the 
linchpins of modern diabetic care, crucial to moving 
the patient closer to set therapeutic goals, regardless 
of the therapy used [11]. The main purpose of educa-
tion is to give knowledge, abilities and motivation to 
control diabetes. It helps achieving therapeutic goals 
agreed with the doctor, and increases effectiveness of 
the therapy [12]. While deliberating the influence of 
education on reaching therapeutic goals, one should 
consider following issues:
1. Scheme and personalization
Education’s essential function is to provide a pos-
sibly unified set of basic terms and information for all 
persons involved, which then enables a dialogue during 
future appointments. However to be effective, educa-
tion should also be personalized and tailored to the 
patient in order to involve him, promote self-reliance 
and motivate him to take partial responsibility for the 
treatment. One way of ensuring this is to encourage 
the patient to set, in cooperation with his physician, 
personal therapeutic goals related to the disease and 
then verify the progress of achieving them. It is not only 
a motivational boost for the patient, but also creates 
a good platform of exchanging information with the 
medical team, concerning the patient’s state of health, 
his needs and attitude towards the therapeutic process.
2. Using educational tools
Another part of an effective education is to pass on 
proper information and tools which allow acting single-
handedly in everyday situations, both typical (e.g. 
regular glycaemia control, dietetic recommendations, 
suggested physical activity or avoiding hypoglycaemia) 
and those requiring special action (e.g. dealing with 
hypoglycaemia or omitting a medication dose) [13]. 
Due to limited time attributed to each patient during 
the visit, it seems promising to point out the educa-
tional tools available between the appointments. These 
consist of traditional means such as brochures, books 
or patient associations’ meetings on the one hand, and 
the rapidly expanding choice of electronic tools such 
as web portals devoted to certain issues, social media, 
blogs, webinars, online or handheld applications on the 
other. Incorporating various educational personnel (e.g. 
nurses, diabetes educators, psychologists, nutritionists, 
personal trainers) [14] into the process of education 
and aiming not only at the patient himself, but also 
at people in his close affinity (e.g. family members or 
other patients in the community), can greatly increase 
the chance of success [15]. 
3. Repetitiveness
Because of the extent of existing knowledge and 
the progressive nature of diabetes an efficient diabetic 
patient education is a constant process, not just a single 
event in the early stages of the disease [16]. In type 1 
diabetes patients, the focus is set right from the start 
on using the intensive insulin therapy. In type 2 patients, 
along with progression of the disease comes the shift-
ing in antihyperglycaemic therapy. Each change in the 
therapeutic scheme should indicate an introduction of 
a corresponding educational panel, covering certain 
topics ranging from oral medication, through basal 
insulin, to mixed insulin and intensive insulin therapy in 
a base-bolus scheme. Elements of education adjusted 
to the patient’s needs and his therapeutic goals in the 
near future should be included in every visit.  
4. Adjusting form — individually and in groups
Benefits of both individual education — provided 
by the therapeutic team or obtained individually via the 
internet or other means — and group education — tra-
ditional lectures, patient meetings, electronic message 
boards effectively reaching more patients, with effects 
lasting longer than a single-meeting education — are 
indisputable. According to some research, group educa-
To amplify my message,  
I’ll speak to you via  
the Internet
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tion is not only equally effective in getting the required 
information through to the patient, but also more cost 
effective and results in a better glycaemia control [17].
5. Up-to-date knowledge 
Efficient diabetic education should keep up with 
modern developments not only when its form is 
concerned, but also when it comes to the content it 
presents. The ever-growing choice of medicaments, 
medical technologies and other solutions — insulin 
pumps, constant glucose measurement systems, 
electronic diabetic and dietary diaries — ought to be 
presented in an accessible manner. 
Passing on the knowledge about diabetes and 
skills necessary to cope with the disease and glycaemia 
control is a challenging task for the educational team, 
and present a great value for the patients. However, 
the fact of being educated itself doesn’t necessarily 
grant the knowledge and practical abilities — these 
should be evaluated and, if necessary, complemented. 
Motivation
One of the elements contributing to achieving 
therapeutic goals is sustaining a satisfactory level of 
patient’s motivation — an inner state that induces 
action towards preservation or improvement of one’s 
state of health [18]. Perceiving the disease as a threat 
and a punishment — or a nuisance and a challenge — 
results in different attitudes towards the disease and 
the therapeutic process [19].
Therapeutic requirements in diabetes concerning 
changes in lifestyle diet, various habits or physical 
activity combined with seemingly non-aggravating 
symptoms — especially in a short term perspective — 
and little awareness of the relation between the therapy 
and those symptoms, make motivating the patient to 
actively take part in the therapeutic process a difficult 
challenge. Analysis of factors affecting the patient’s 
motivational processes in chronic disease unequivo-
cally show their complex and multi-dimensional influ-
ence on patient’s behaviour [20–23]. In authors’ own 
opinion based on personal experience, the key factors 
in a therapeutic management of diabetic patients are:
1. Setting the goal accordingly
Personalization of therapeutic goals in a given stage 
of the disease, their acceptation and understanding by 
the patient. Creating an adequate timeline and enabling 
evaluation to mark progress, often by dividing the goals 
into stages. Confronting ambitions with reality.
2. Making the goals important 
Finding a goal more valuable than others, one 
that can fulfil real needs of the patients, and therefore 
become a determinant of their actions in the long run. 
3. Positive motivation
Regarded as sustaining an “aspiring for” attitude 
— which grows stronger as the patient gets closer to 
the promised reward. It should facilitate meeting the 
patients’ needs, e.g. allowing better glycaemia control 
— the goal — which then lowers the risk of complica-
tions — blindness, amputation, the need for dialysis, 
granting longer life expectancy or a chance to give 
birth to a healthy infant — the reward. It is important 
to appreciate even minor achievements of the patient.
4. A cause-effect relationship between  
the patients’ actions and his health
Giving a real sense of control of the disease, rein-
forcing awareness of the effects of actions both taken 
and omitted. 
5. Motivational atmosphere
Resulting from the doctor-patient relationship 
and transferring the patient’s approval for proposed 
therapy from the doctor’s office (where the require-
ments seem easy to fulfil) to the patient’s everyday life 
and surroundings. 
When treating diabetes in children, inducing moti-
vation in the child’s parents is also crucial, as children 
tend to subconsciously mimic the parents’ attitude. 
Pointing out the importance of determination in con-
trolling the disease as the main way of assuring proper 
physical, intellectual and social development in their 
children’s future — to a degree that had been expected 
before the disease occurred — is also an important 
way of promoting positive motivation. Motivational 
techniques concerning children vary depending on the 
patient’s age and will be presented in a different article. 
A perfect example that pictures the potential of motiva-
It’s fantastic!  
The doctor applauded  
me and noticed my  
minor achievements!
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tion in therapy, are diabetic women who either plan 
pregnancy, or get pregnant at some point. The desire 
to give birth to healthy child results in better metabolic 
control in well educated patients during pregnancy 
when compared to other periods of their lives.
Systemic measures
Systemic measures are a difficult issue to elaborate 
on, as they rely on the organisation of medical care in 
different societies, leaving both doctors and patients 
little influence to be had. An organized effort could 
be expected from various groups and associations, 
formed by specialists, patients and doctors. The role of 
specialist organizations is creating standards of care on 
the basis of merit, whereas the patient groups should 
apply civic pressure on the decision-makers, to make 
sure these standards are in fact fulfilled. 
Therapy
Therapeutic measures currently available in clinical 
practice enable a multidimensional influence on the 
pathophysiology of diabetes. Randomized controlled 
clinical trials and meta-analyzes determine the effects 
expected while using certain drug groups — or different 
groups combined — regarding their safety profile and 
efficiency. Clinical guidelines also clearly state reason-
able models of initiating and intensifying therapies. 
The ability to choose between the given tools, ways 
and intensity of therapy is, from the doctor’s point of 
view, a truly desired situation. There is no doubt that 
the doctor’s choices may also influence the quality of 
doctor-patient cooperation in the therapeutic process. 
Personalization
According to clinical guidelines, making a thera-
peutic choice should be a result of a broad analysis of 
many different clinical and personal features of the 
patient, e.g. his attitude and expected commitment 
to therapy, diabetic education level, risk of hypogly-
caemic events and their consequences, duration of 
diabetes, life expectancy, presence of serious vascular 
complications and significant concomitant diseases. 
The guidelines do not discriminate the importance 
of each criterion. The choice of therapy should be 
made based on a complex patient’s profile, taking his 
expectations into account. From the patient’s point of 
view, an optimal therapy is most likely a simple, easy 
to remember and easy to use scheme which is effective 
and causes no side effects. For each patient — or for the 
same patient in different stages of the disease — the 
significance of these elements changes, from “I want 
it to be effective” or “I am afraid of hypoglycaemia” 
to “I will surely gain weight”. Taking the key patient’s 
expectations and fears into account may contribute to 
a more effective cooperation in the long run (Fig. 2). 
Practical algorithms for unassisted  
patient decisions
It is obvious that reaching therapeutic goals in 
diabetes requires the patient to actively take part in the 
Naturally, I treat  
each patient  
individually
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process at every stage of therapy. One of the solutions 
that strengthen the sense of having control over the 
disease is frequently using algorithms in clinical prac-
tice, which enable the patients to adjust the medica-
tion doses themselves, based on an honest glycaemia 
control. A 3-0-3 algorithm for patient-managed basal 
insulin — detemir — therapy intensification, reviewed 
in TITRATE [24] clinical trial, is an example of such solu-
tion. It enables adjusting the dosage of basal insulin in 
between the appointments by the patient himself. As 
a result the therapeutic goal defined as HbA1c < 7% 
with low risk of hypoglycaemia was achieved by 54.5% 
of patients with type 2 diabetes, who used insulin 
based therapy with detemir once a day. The option of 
patient-managed dose control was also indicated in 
the Summary of Product’s Characteristic for detemir 
(Table 2) [25]. Patient-managed dose adjusting was 
also evaluated in a basal insulin therapy intensification 
model by adding additional postprandial injections of 
rapid-acting analogue [26]. In this project, the dose of 
mealtime insulin — aspart — was adjusted within one 
unit range — +1, 0, –1 — based on the glycaemia levels 
before the meal, or before going to sleep. 
Flexibility of the therapeutic scheme
The chronic nature of therapy of diabetes and its 
inseparable connection with everyday activity naturally 
makes the patient expect the recommended therapeutic 
scheme to be as flexible as possible. Therefore, such 
point of view shouldn’t be overlooked while making 
therapeutic decisions. For example, the various recom-
mended timings of prandial insulin injections (e.g. right 
before, during or after the meal for a rapid acting ana-
logue compared to 20–30 minutes beforehand for hu-
man insulin) can greatly influence the way the patient 
perceives the therapy. Another interesting example of 
taking this aspect into consideration is the possibility 
of — if needed — injecting the degludec insulin, an 
ultra-long lasting base insulin, with a shift in time, 
determined in the Summary of Product’s Characteristic 
as 8 to 40 hours after previous injection [27].
Summary
Taking the patient’s point of view into considera-
tion in everyday therapeutic decisions and personal-
izing the therapeutic process based on his clinical and 
psychological profile undoubtedly set a clear direction 
for diabetes specialists and will remain relevant in the 
future. Compliance defined as the quality of purpose-
ful and mutual cooperation seems to be fundamental 
in increasing the chance of making optimal choices 
and reaching the goals of proposed therapy. Rais-
ing the quality of this cooperation requires not only 
a personalized therapeutic approach and organized 
education in an innovative form, but also demands a 
systematic increase in doctors’ expertise in effective 
communication and motivational techniques used in 
a therapeutic process. 
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